Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi Stock
Equities
GENIL
TREGENL00024
Pharmaceuticals
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
56.95 TRY | -1.39% | -3.88% | +21.48% |
Sales 2022 | 5.45B 168M 229M | Sales 2023 | 8.15B 252M 343M | Capitalization | 14.06B 435M 592M |
---|---|---|---|---|---|
Net income 2022 | 1.08B 33.38M 45.48M | Net income 2023 | 455M 14.06M 19.16M | EV / Sales 2022 | 2.76 x |
Net cash position 2022 | 494M 15.28M 20.81M | Net Debt 2023 | 594M 18.36M 25.01M | EV / Sales 2023 | 1.8 x |
P/E ratio 2022 |
14.4
x | P/E ratio 2023 |
30.9
x | Employees | 622 |
Yield 2022 |
2.15% | Yield 2023 |
-
| Free-Float | 25.75% |
1 day | -1.39% | ||
1 week | -3.88% | ||
Current month | -14.87% | ||
1 month | -14.87% | ||
3 months | +8.17% | ||
6 months | -6.56% | ||
Current year | +21.48% |
Managers | Title | Age | Since |
---|---|---|---|
Nadir Ulu
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-30 |
Ali Ketencioglu
IRC | Investor Relations Contact | - | 21-08-31 |
Sales & Marketing | - | 10-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Abidin Gulmus
CHM | Chairman | - | - |
Sukru Turkmen
BRD | Director/Board Member | - | - |
Ömer Dinçer
BRD | Director/Board Member | - | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 56.95 | -1.39% | 698 944 |
24-04-26 | 57.75 | +0.43% | 966,063 |
24-04-25 | 57.5 | +0.26% | 787,715 |
24-04-24 | 57.35 | -3.21% | 1,538,479 |
24-04-22 | 59.25 | +1.11% | 1,632,512 |
Delayed Quote Borsa Istanbul, April 29, 2024 at 07:56 am
More quotes1st Jan change | Capi. | |
---|---|---|
+21.48% | 534M | |
+25.83% | 661B | |
+26.47% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.60% | 231B | |
+5.37% | 200B | |
-8.92% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- GENIL Stock